-
India to lose over $4.58 trillion to non-communicable diseases
India stands to lose $4.58 trillion due to non-communicable diseases and mental disorders between 2012 and 2030, an amount more than double India's annualGDP, according to a report.
- Categories
- Health Care
- Region
- South Asia
-
Pharmaceuticals industry facing fundamental change
Pharmaceuticals is an extraordinarily profitable business.
- Categories
- Health Care
- Tags
- impact investing
-
Apollo Hospitals to focus on rural areas
Apollo Hospitals plans to ride the next wave of growth with expansion in rural sector, Prathap C Reddy, Chairman, said. The hospital chain plans to add at least 14 Reach Hospitals in rural regions at a cost of ? 1,800 crore by 2016 and plans more in the coming years.
- Categories
- Health Care
- Region
- South Asia
-
Shaping the Market for Global Health Data: Why collecting information on lower-income countries should be ‘first order of business’
The most valuable currency in global health programs today is accurate and reliable data, but such data doesn’t exist for most low-income and lower-middle-income countries – primarily because it’s expensive. The authors discuss why, and how, more data might become available.
- Categories
- Health Care
-
World’s 1st dengue vaccine likely by 2015: Sanofi
As India deals with increasing number of dengue fever, pharma major Sanofi today said the world's first vaccine against the mosquito-borne viral disease may be available by the second half of 2015.
- Categories
- Health Care
-
Airtel joins GSMA’s mobile health programme
Bharti Airtel today said it has joined GSMA's mobile health partnership programme which aims to provide a range of services to women and children across 11 countries in Sub-Saharan Africa.
- Categories
- Health Care, Technology
-
India next on Abbott’s global rebranding map
In a bid to reach out and engage with consumers more, the $22-billion US healthcare major Abbott is redefining its corporate identity, with India becoming one of the first markets after the US and Brazil where the change is being rolled out.
- Categories
- Health Care
- Region
- South Asia
-
Bill Gates-Backed Group Weighs Funding for Ebola Vaccine
As GlaxoSmithKline Plc (GSK) and other drugmakers race to develop and deploy vaccines against West Africa’s Ebola outbreak, one key question remains: who will pay?
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.